Pharmaceutical

Novo Nordisk cuts Wegovy price through new direct-to-pa...

Novo Nordisk increases efforts to rebuff pressures from the compounding marketpl...

Trimtech closes seed fund round to advance CNS therapeu...

Trimtech Therapeutics has closed a seed funding round of $31m (£25m) to advance ...

Callio raises $187m for proof-of-concept for dual-paylo...

Callio Therapeutics has raised $187m in Series A financing round for achieving c...

Are European biopharma manufacturers ‘nearshoring’?

Experts debate whether European manufacturers are preferring domestic operations...

Machine learning adoption into supply chain management ...

Large-scale integration of AI into pharma supply chains is on the way as compani...

Reflecting on a milestone year for cell and gene therapies

Cell and gene therapies have undergone notable milestones in the last 12 months,...

Genentech wins FDA approval for second stroke treatment

Genentech’s label expansion for TNKase consolidates its market position for phar...

EU set to approve AstraZeneca’s Imfinzi-chemo combo for...

AstraZeneca's Imfinzi (durvalumab) plus chemotherapy, has gained CHMP recommenda...

MWC Barcelona 2025: Huawei unveils global showcases alo...

During MWC Barcelona 2025 Huawei brought together customers & partners to explor...

MWC Barcelona 2025: Maximizing 5G network value in the ...

At MWC Barcelona 2025, Li Peng delivered a keynote on how carriers can make the ...

FDA approves BeiGene’s Tevimbra plus chemo for oesophag...

The FDA has approved BeiGene’s Tevimbra with chemotherapy for treating oesophage...

Antibody drug conjugates: Tackling the unsolved challen...

ADCs are currently at the forefront of cancer treatment, but persistent drug dev...

Magnet Biomedicine and Lilly link for molecular glue th...

Magnet Biomedicine has entered a partnership and licence agreement with Eli Lill...

New EU trial regulations could expedite approvals and a...

New EU Clinical Trial Regulations simplify international trials while offering t...

Inborn errors of metabolism elicit unique challenges fo...

As Rare Disease Day is commemorated on 28 February, experts discuss the barriers...

CHMP recommends AbbVie’s Rinvoq be approved for adult GCA

The CHMP has recommended the approval of AbbVie's upadacitinib (Rinvoq) for trea...